University of California Melanoma and Skin Cancer Consortium | Feb. 21, 2026
Bridging Research and Patient Care in Melanoma
This symposium brings together leading melanoma experts to provide a comprehensive overview of melanoma care—from early-stage diagnosis and treatment to advanced and metastatic disease, along with the latest research shaping the future. Across these sessions, you’ll gain a clear understanding of how melanoma develops, how treatments like immunotherapy and targeted therapy work, and how new approaches such as ctDNA monitoring, TIL therapy, and personalized vaccines are changing outcomes for patients. Designed for patients, caregivers, and healthcare professionals alike, this symposium offers trusted, expert-led insights to help you better understand today’s treatment landscape and what lies ahead.
Full Symposium
Presenters & Topics
Challenges and Opportunities in Melanoma Care
Gregory A Daniels, MD, PhD
Medical Oncologist
Professor of Medicine
UC San Diego Moores Cancer Center
Circulating Tumor (ct)-DNA in Melanoma
Warren A Chow MD
Clinical Professor
Division of Hematology/Oncology
Associate Director for Clinic Sciences
University of California Irvine, Chao Family Comprehensive Cancer Center
Targeted Therapy in Melanoma
Poorva Vaidya, MD
Assistant Professor
Division of Hematology/Oncology
University of California Irvine, Chao Family Comprehensive Cancer Center
Pivotal Trials in Early-Stage Melanoma
Afsaneh Amouzegar, MD
Medical Oncologist
Assistant Professor of Medicine
University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
Pivotal Trials in Late-Stage Melanoma
Derrick L. Tao, MD
Medical Oncologist
Assistant Professor of Medicine
University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
Future Research Directions in Melanoma
Adil Daud, MD
Professor of Clinical Medicine and Dermatology
Director, Melanoma Clinical Research
University of California San Francisco, Helen Diller Family Comprehensive Cancer Center